Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

374 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intraperitoneal pharmacokinetics of systemic oxaliplatin, 5-fluorouracil and bevacizumab in patients with colorectal peritoneal metastases.
Rietveld PCS, Guchelaar NAD, van Eerden RAG, de Boer NL, de Bruijn P, Sassen SDT, Madsen EVE, Koch BCP, Verhoef C, Burger JWA, Mathijssen RHJ, Koolen SLW. Rietveld PCS, et al. Among authors: de boer nl. Biomed Pharmacother. 2024 May 28;176:116820. doi: 10.1016/j.biopha.2024.116820. Online ahead of print. Biomed Pharmacother. 2024. PMID: 38810398 Free article.
Fecal microbiota and volatile metabolome pattern alterations precede late-onset meningitis in preterm neonates.
Frerichs NM, Deianova N, El Manouni El Hassani S, Acharjee A, Quraishi MN, de Boode WP, Cossey V, Hulzebos CV, van Kaam AH, Kramer BW, d'Haens E, de Jonge WJ, Vijlbrief DC, van Weissenbruch MM, Daulton E, Wicaksono AN, Covington JA, Benninga MA, de Boer NKH, van Goudoever JB, Niemarkt HJ, de Meij TGJ. Frerichs NM, et al. Among authors: de boer nkh. J Infect Dis. 2024 May 23:jiae265. doi: 10.1093/infdis/jiae265. Online ahead of print. J Infect Dis. 2024. PMID: 38781449
Population pharmacokinetics of intraperitoneal irinotecan and SN-38 in patients with peritoneal metastases from colorectal origin.
Rietveld PCS, Sassen SDT, Guchelaar NAD, van Eerden RAG, de Boer NL, van den Heuvel TBM, Burger JWA, Mathijssen RHJ, Koch BCP, Koolen SLW. Rietveld PCS, et al. Among authors: de boer nl. CPT Pharmacometrics Syst Pharmacol. 2024 Apr 17. doi: 10.1002/psp4.13136. Online ahead of print. CPT Pharmacometrics Syst Pharmacol. 2024. PMID: 38634204 Free article.
A Prediction Model for Successful Increase of Adalimumab Dose Intervals in Patients with Crohn's Disease: Secondary Analysis of the Pragmatic Open-Label Randomised Controlled Non-inferiority LADI Trial.
van Linschoten RCA, Jansen FM, Pauwels RWM, Smits LJT, Atsma F, Kievit W, de Jong DJ, de Vries AC, Boekema PJ, West RL, Bodelier AGL, Gisbertz IAM, Wolfhagen FHJ, Römkens TEH, Lutgens MWMD, van Bodegraven AA, Oldenburg B, Pierik MJ, Russel MGVM, de Boer NK, Mallant-Hent RC, Ter Borg PCJ, van der Meulen-de Jong AE, Jansen JM, Jansen SV, Tan ACITL, van der Woude CJ, Hoentjen F; LADI study group, the Dutch Initiative on Crohn, Colitis (ICC). van Linschoten RCA, et al. Among authors: de boer nk. Dig Dis Sci. 2024 Apr 9. doi: 10.1007/s10620-024-08410-z. Online ahead of print. Dig Dis Sci. 2024. PMID: 38594435
Interobserver agreement of current and new proposed endoscopic scores for postoperative recurrence in Crohn's disease.
Bak MTJ, Hammoudi N, Allez M, Silverberg MS, Schellekens IM, Erler NS, Dijkstra G, Romberg-Camps M, de Boer NKH, Jansen SV, van der Marel S, Horjus CS, Visschedijk MC, Goetgebuer RL, van Dop WA, Hoekstra J, Bodelier AGL, Molendijk I, Derikx LAAP, van Schaik FDM, West RL, Duijvestein M, van der Woude CJ, van Ruler O, de Vries AC; Dutch Initiative on Crohn and Colitis and the RAP-CD study group. Bak MTJ, et al. Among authors: de boer nkh. Gastrointest Endosc. 2024 Mar 8:S0016-5107(24)00164-0. doi: 10.1016/j.gie.2024.03.011. Online ahead of print. Gastrointest Endosc. 2024. PMID: 38462057 Free article.
374 results